Menu
The second group of high-cost prescription drugs chosen for Medicare price negotiations were announced last week just ahead of former President Joe Biden's departure from the White House.

New CMS Rule Mulls Data Repository for 340B Claims in 2026, But Implementation Challenges Loom

William Newton, Associate Editor/Senior Writer 340B Report Views
Federal regulators are exploring a data repository to identify 340B claims to exclude from certain Medicare inflation rebates in 2026 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Tammy Kinney:  A Personal Testament to 340B’s Importance in Rural America

Senate GOP Selects Thune, a 340B Champion, as Next Majority Leader Despite Pushback from Trump Allies

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live